268 related articles for article (PubMed ID: 21857646)
21. Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.
Wang Z; Wang B; Shi Y; Xu C; Xiao HL; Ma LN; Xu SL; Yang L; Wang QL; Dang WQ; Cui W; Yu SC; Ping YF; Cui YH; Kung HF; Qian C; Zhang X; Bian XW
Oncogene; 2015 Mar; 34(11):1407-19. PubMed ID: 24704830
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1.
Ding LJ; Li Y; Wang SD; Wang XS; Fang F; Wang WY; Lv P; Zhao DH; Wei F; Qi L
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669232
[TBL] [Abstract][Full Text] [Related]
23. Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133.
Chai S; Tong M; Ng KY; Kwan PS; Chan YP; Fung TM; Lee TK; Wong N; Xie D; Yuan YF; Guan XY; Ma S
Oncotarget; 2014 Jul; 5(14):5725-35. PubMed ID: 25015418
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-153 is tumor suppressive in glioblastoma stem cells.
Zhao S; Deng Y; Liu Y; Chen X; Yang G; Mu Y; Zhang D; Kang J; Wu Z
Mol Biol Rep; 2013 Apr; 40(4):2789-98. PubMed ID: 23397238
[TBL] [Abstract][Full Text] [Related]
25. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.
Li Y; Li A; Glas M; Lal B; Ying M; Sang Y; Xia S; Trageser D; Guerrero-Cázares H; Eberhart CG; Quiñones-Hinojosa A; Scheffler B; Laterra J
Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9951-6. PubMed ID: 21628563
[TBL] [Abstract][Full Text] [Related]
26. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
[TBL] [Abstract][Full Text] [Related]
27. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.
Ying M; Wang S; Sang Y; Sun P; Lal B; Goodwin CR; Guerrero-Cazares H; Quinones-Hinojosa A; Laterra J; Xia S
Oncogene; 2011 Aug; 30(31):3454-67. PubMed ID: 21383690
[TBL] [Abstract][Full Text] [Related]
28. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
Yang L; Yan Z; Wang Y; Ma W; Li C
Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
[TBL] [Abstract][Full Text] [Related]
29. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract][Full Text] [Related]
30. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
[TBL] [Abstract][Full Text] [Related]
31. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT
Wang J; Qin C; Zhong C; Wen Y; Ke S; Liao BO
J Biosci; 2020; 45():. PubMed ID: 32975234
[TBL] [Abstract][Full Text] [Related]
34. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
35. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
36. Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.
Shin JH; Lee YS; Hong YK; Kang CS
J Neurooncol; 2013 Dec; 115(3):333-41. PubMed ID: 24129546
[TBL] [Abstract][Full Text] [Related]
37. Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma.
Nakai E; Park K; Yawata T; Chihara T; Kumazawa A; Nakabayashi H; Shimizu K
Cancer Invest; 2009 Nov; 27(9):901-8. PubMed ID: 19832037
[TBL] [Abstract][Full Text] [Related]
38. miR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b.
Wan Y; Sun G; Wang Z; Guo J; Shi L
Neuroreport; 2014 Mar; 25(5):289-96. PubMed ID: 24356103
[TBL] [Abstract][Full Text] [Related]
39. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations.
Yan X; Ma L; Yi D; Yoon JG; Diercks A; Foltz G; Price ND; Hood LE; Tian Q
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1591-6. PubMed ID: 21220328
[TBL] [Abstract][Full Text] [Related]
40. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
